nodes	percent_of_prediction	percent_of_DWPC	metapath
Ruxolitinib—MARK2—thyroid gland—hypothyroidism	0.00245	0.00368	CbGeAlD
Ruxolitinib—PLK4—gonad—hypothyroidism	0.00245	0.00368	CbGeAlD
Ruxolitinib—CAMK1—female gonad—hypothyroidism	0.00244	0.00366	CbGeAlD
Ruxolitinib—DAPK3—cardiovascular system—hypothyroidism	0.00243	0.00366	CbGeAlD
Ruxolitinib—DYRK1A—heart—hypothyroidism	0.00241	0.00363	CbGeAlD
Ruxolitinib—BMPR2—heart—hypothyroidism	0.00241	0.00361	CbGeAlD
Ruxolitinib—JAK1—pituitary gland—hypothyroidism	0.0024	0.00361	CbGeAlD
Ruxolitinib—DCLK1—pituitary gland—hypothyroidism	0.0024	0.00361	CbGeAlD
Ruxolitinib—PHKG2—gonad—hypothyroidism	0.00239	0.00359	CbGeAlD
Ruxolitinib—TAOK2—adrenal gland—hypothyroidism	0.00235	0.00353	CbGeAlD
Ruxolitinib—TAOK2—blood—hypothyroidism	0.00235	0.00353	CbGeAlD
Ruxolitinib—CAMK1D—pituitary gland—hypothyroidism	0.00234	0.00352	CbGeAlD
Ruxolitinib—ROCK1—cardiovascular system—hypothyroidism	0.00234	0.00351	CbGeAlD
Ruxolitinib—PLK3—testis—hypothyroidism	0.00231	0.00347	CbGeAlD
Ruxolitinib—HIPK2—gonad—hypothyroidism	0.0023	0.00345	CbGeAlD
Ruxolitinib—DYRK1A—cardiovascular system—hypothyroidism	0.00228	0.00342	CbGeAlD
Ruxolitinib—BMPR2—cardiovascular system—hypothyroidism	0.00227	0.00341	CbGeAlD
Ruxolitinib—TAOK2—thyroid gland—hypothyroidism	0.00227	0.00341	CbGeAlD
Ruxolitinib—STK16—pituitary gland—hypothyroidism	0.00225	0.00339	CbGeAlD
Ruxolitinib—LTK—testis—hypothyroidism	0.00223	0.00336	CbGeAlD
Ruxolitinib—TAOK2—female gonad—hypothyroidism	0.00219	0.00329	CbGeAlD
Ruxolitinib—CLK2—gonad—hypothyroidism	0.00219	0.00329	CbGeAlD
Ruxolitinib—PLK3—liver—hypothyroidism	0.00219	0.00328	CbGeAlD
Ruxolitinib—CAMK1—testis—hypothyroidism	0.00216	0.00325	CbGeAlD
Ruxolitinib—JAK3—adrenal gland—hypothyroidism	0.00216	0.00324	CbGeAlD
Ruxolitinib—JAK3—blood—hypothyroidism	0.00216	0.00324	CbGeAlD
Ruxolitinib—DAPK3—pituitary gland—hypothyroidism	0.00215	0.00324	CbGeAlD
Ruxolitinib—CAMK2G—heart—hypothyroidism	0.00215	0.00323	CbGeAlD
Ruxolitinib—BMP2K—heart—hypothyroidism	0.00215	0.00323	CbGeAlD
Ruxolitinib—JAK1—adrenal gland—hypothyroidism	0.00215	0.00322	CbGeAlD
Ruxolitinib—DCLK1—adrenal gland—hypothyroidism	0.00215	0.00322	CbGeAlD
Ruxolitinib—JAK1—blood—hypothyroidism	0.00215	0.00322	CbGeAlD
Ruxolitinib—CLK2—pituitary gland—hypothyroidism	0.00213	0.00321	CbGeAlD
Ruxolitinib—LRRK2—heart—hypothyroidism	0.00213	0.0032	CbGeAlD
Ruxolitinib—PLK4—adrenal gland—hypothyroidism	0.00213	0.0032	CbGeAlD
Ruxolitinib—PLK4—blood—hypothyroidism	0.00213	0.0032	CbGeAlD
Ruxolitinib—ROCK1—gonad—hypothyroidism	0.00212	0.00318	CbGeAlD
Ruxolitinib—MARK2—testis—hypothyroidism	0.0021	0.00315	CbGeAlD
Ruxolitinib—CAMK1D—adrenal gland—hypothyroidism	0.00209	0.00315	CbGeAlD
Ruxolitinib—CAMK1D—blood—hypothyroidism	0.00209	0.00315	CbGeAlD
Ruxolitinib—JAK3—thyroid gland—hypothyroidism	0.00208	0.00313	CbGeAlD
Ruxolitinib—PHKG2—adrenal gland—hypothyroidism	0.00208	0.00313	CbGeAlD
Ruxolitinib—JAK1—thyroid gland—hypothyroidism	0.00207	0.00311	CbGeAlD
Ruxolitinib—DCLK1—thyroid gland—hypothyroidism	0.00207	0.00311	CbGeAlD
Ruxolitinib—DYRK1A—gonad—hypothyroidism	0.00207	0.00311	CbGeAlD
Ruxolitinib—DAPK2—adrenal gland—hypothyroidism	0.00205	0.00308	CbGeAlD
Ruxolitinib—DAPK2—blood—hypothyroidism	0.00205	0.00307	CbGeAlD
Ruxolitinib—CAMK1—liver—hypothyroidism	0.00205	0.00307	CbGeAlD
Ruxolitinib—CAMK2G—cardiovascular system—hypothyroidism	0.00203	0.00305	CbGeAlD
Ruxolitinib—CAMK1D—thyroid gland—hypothyroidism	0.00202	0.00304	CbGeAlD
Ruxolitinib—STK16—adrenal gland—hypothyroidism	0.00201	0.00303	CbGeAlD
Ruxolitinib—STK16—blood—hypothyroidism	0.00201	0.00302	CbGeAlD
Ruxolitinib—JAK3—female gonad—hypothyroidism	0.00201	0.00302	CbGeAlD
Ruxolitinib—BMPR2—pituitary gland—hypothyroidism	0.00201	0.00302	CbGeAlD
Ruxolitinib—PHKG2—thyroid gland—hypothyroidism	0.00201	0.00302	CbGeAlD
Ruxolitinib—HIPK2—adrenal gland—hypothyroidism	0.002	0.00301	CbGeAlD
Ruxolitinib—MAP3K7—adrenal cortex—hypothyroidism	0.002	0.00301	CbGeAlD
Ruxolitinib—JAK1—female gonad—hypothyroidism	0.002	0.00301	CbGeAlD
Ruxolitinib—CAMK1—cerebellum—hypothyroidism	0.002	0.003	CbGeAlD
Ruxolitinib—DAPK2—thyroid gland—hypothyroidism	0.00198	0.00297	CbGeAlD
Ruxolitinib—TYK2—adrenal cortex—hypothyroidism	0.00197	0.00295	CbGeAlD
Ruxolitinib—MAP3K2—heart—hypothyroidism	0.00195	0.00294	CbGeAlD
Ruxolitinib—CAMK1D—female gonad—hypothyroidism	0.00195	0.00293	CbGeAlD
Ruxolitinib—STK16—thyroid gland—hypothyroidism	0.00194	0.00292	CbGeAlD
Ruxolitinib—TAOK2—testis—hypothyroidism	0.00194	0.00292	CbGeAlD
Ruxolitinib—PHKG2—female gonad—hypothyroidism	0.00194	0.00292	CbGeAlD
Ruxolitinib—MKNK2—adrenal cortex—hypothyroidism	0.00194	0.00291	CbGeAlD
Ruxolitinib—MARK2—cerebellum—hypothyroidism	0.00194	0.00291	CbGeAlD
Ruxolitinib—MAP3K7—heart—hypothyroidism	0.00194	0.00291	CbGeAlD
Ruxolitinib—HIPK2—thyroid gland—hypothyroidism	0.00193	0.0029	CbGeAlD
Ruxolitinib—DAPK3—adrenal gland—hypothyroidism	0.00192	0.00289	CbGeAlD
Ruxolitinib—DAPK3—blood—hypothyroidism	0.00192	0.00289	CbGeAlD
Ruxolitinib—NUAK2—pituitary gland—hypothyroidism	0.00192	0.00288	CbGeAlD
Ruxolitinib—DAPK2—female gonad—hypothyroidism	0.00191	0.00287	CbGeAlD
Ruxolitinib—CLK2—adrenal gland—hypothyroidism	0.00191	0.00286	CbGeAlD
Ruxolitinib—CLK2—blood—hypothyroidism	0.00191	0.00286	CbGeAlD
Ruxolitinib—TYK2—heart—hypothyroidism	0.0019	0.00286	CbGeAlD
Ruxolitinib—STK16—female gonad—hypothyroidism	0.00188	0.00282	CbGeAlD
Ruxolitinib—IRAK1—heart—hypothyroidism	0.00188	0.00282	CbGeAlD
Ruxolitinib—MKNK2—heart—hypothyroidism	0.00188	0.00282	CbGeAlD
Ruxolitinib—HIPK2—female gonad—hypothyroidism	0.00187	0.00281	CbGeAlD
Ruxolitinib—DAPK3—thyroid gland—hypothyroidism	0.00186	0.00279	CbGeAlD
Ruxolitinib—ROCK1—blood—hypothyroidism	0.00185	0.00278	CbGeAlD
Ruxolitinib—BMP2K—gonad—hypothyroidism	0.00184	0.00277	CbGeAlD
Ruxolitinib—CLK2—thyroid gland—hypothyroidism	0.00184	0.00276	CbGeAlD
Ruxolitinib—TAOK2—liver—hypothyroidism	0.00184	0.00276	CbGeAlD
Ruxolitinib—RET—heart—hypothyroidism	0.00183	0.00275	CbGeAlD
Ruxolitinib—LRRK2—gonad—hypothyroidism	0.00183	0.00274	CbGeAlD
Ruxolitinib—DYRK1A—adrenal gland—hypothyroidism	0.0018	0.00271	CbGeAlD
Ruxolitinib—CYP3A4—urine—hypothyroidism	0.0018	0.00271	CbGeAlD
Ruxolitinib—CAMK2G—pituitary gland—hypothyroidism	0.0018	0.0027	CbGeAlD
Ruxolitinib—BMPR2—adrenal gland—hypothyroidism	0.0018	0.0027	CbGeAlD
Ruxolitinib—TAOK2—cerebellum—hypothyroidism	0.00179	0.0027	CbGeAlD
Ruxolitinib—DAPK3—female gonad—hypothyroidism	0.00179	0.0027	CbGeAlD
Ruxolitinib—TYK2—cardiovascular system—hypothyroidism	0.00179	0.00269	CbGeAlD
Ruxolitinib—JAK3—testis—hypothyroidism	0.00179	0.00268	CbGeAlD
Ruxolitinib—LRRK2—pituitary gland—hypothyroidism	0.00178	0.00268	CbGeAlD
Ruxolitinib—CLK2—female gonad—hypothyroidism	0.00178	0.00267	CbGeAlD
Ruxolitinib—JAK1—testis—hypothyroidism	0.00177	0.00267	CbGeAlD
Ruxolitinib—DCLK1—testis—hypothyroidism	0.00177	0.00267	CbGeAlD
Ruxolitinib—MKNK2—cardiovascular system—hypothyroidism	0.00177	0.00266	CbGeAlD
Ruxolitinib—PLK4—testis—hypothyroidism	0.00176	0.00265	CbGeAlD
Ruxolitinib—DYRK1A—thyroid gland—hypothyroidism	0.00174	0.00261	CbGeAlD
Ruxolitinib—BMPR2—thyroid gland—hypothyroidism	0.00173	0.0026	CbGeAlD
Ruxolitinib—CAMK1D—testis—hypothyroidism	0.00173	0.0026	CbGeAlD
Ruxolitinib—JAK2—heart—hypothyroidism	0.00173	0.0026	CbGeAlD
Ruxolitinib—MAP3K3—adrenal cortex—hypothyroidism	0.00172	0.00259	CbGeAlD
Ruxolitinib—ROCK1—female gonad—hypothyroidism	0.00172	0.00259	CbGeAlD
Ruxolitinib—PHKG2—testis—hypothyroidism	0.00172	0.00259	CbGeAlD
Ruxolitinib—NUAK2—adrenal gland—hypothyroidism	0.00172	0.00258	CbGeAlD
Ruxolitinib—NUAK2—blood—hypothyroidism	0.00172	0.00258	CbGeAlD
Ruxolitinib—DAPK2—testis—hypothyroidism	0.00169	0.00254	CbGeAlD
Ruxolitinib—DYRK1A—female gonad—hypothyroidism	0.00168	0.00252	CbGeAlD
Ruxolitinib—JAK1—liver—hypothyroidism	0.00168	0.00252	CbGeAlD
Ruxolitinib—BMPR2—female gonad—hypothyroidism	0.00167	0.00251	CbGeAlD
Ruxolitinib—MAP3K2—gonad—hypothyroidism	0.00167	0.00251	CbGeAlD
Ruxolitinib—MAP3K3—heart—hypothyroidism	0.00167	0.0025	CbGeAlD
Ruxolitinib—STK16—testis—hypothyroidism	0.00167	0.0025	CbGeAlD
Ruxolitinib—HIPK2—testis—hypothyroidism	0.00166	0.00249	CbGeAlD
Ruxolitinib—NUAK2—thyroid gland—hypothyroidism	0.00166	0.00249	CbGeAlD
Ruxolitinib—JAK3—cerebellum—hypothyroidism	0.00165	0.00248	CbGeAlD
Ruxolitinib—JAK1—cerebellum—hypothyroidism	0.00164	0.00246	CbGeAlD
Ruxolitinib—DCLK1—cerebellum—hypothyroidism	0.00164	0.00246	CbGeAlD
Ruxolitinib—CAMK1D—liver—hypothyroidism	0.00164	0.00246	CbGeAlD
Ruxolitinib—JAK2—cardiovascular system—hypothyroidism	0.00163	0.00245	CbGeAlD
Ruxolitinib—PHKG2—liver—hypothyroidism	0.00163	0.00245	CbGeAlD
Ruxolitinib—MAP3K19—testis—hypothyroidism	0.00162	0.00244	CbGeAlD
Ruxolitinib—MAP3K7—pituitary gland—hypothyroidism	0.00162	0.00243	CbGeAlD
Ruxolitinib—MKNK2—gonad—hypothyroidism	0.00161	0.00241	CbGeAlD
Ruxolitinib—CAMK2G—adrenal gland—hypothyroidism	0.00161	0.00241	CbGeAlD
Ruxolitinib—BMP2K—adrenal gland—hypothyroidism	0.00161	0.00241	CbGeAlD
Ruxolitinib—BMP2K—blood—hypothyroidism	0.00161	0.00241	CbGeAlD
Ruxolitinib—CAMK2G—blood—hypothyroidism	0.00161	0.00241	CbGeAlD
Ruxolitinib—CAMK1D—cerebellum—hypothyroidism	0.0016	0.0024	CbGeAlD
Ruxolitinib—NUAK2—female gonad—hypothyroidism	0.0016	0.0024	CbGeAlD
Ruxolitinib—LRRK2—adrenal gland—hypothyroidism	0.00159	0.00239	CbGeAlD
Ruxolitinib—DAPK3—testis—hypothyroidism	0.00159	0.00239	CbGeAlD
Ruxolitinib—LRRK2—blood—hypothyroidism	0.00159	0.00239	CbGeAlD
Ruxolitinib—PHKG2—cerebellum—hypothyroidism	0.00159	0.00239	CbGeAlD
Ruxolitinib—TYK2—pituitary gland—hypothyroidism	0.00159	0.00239	CbGeAlD
Ruxolitinib—CLK2—testis—hypothyroidism	0.00158	0.00237	CbGeAlD
Ruxolitinib—STK16—liver—hypothyroidism	0.00157	0.00237	CbGeAlD
Ruxolitinib—MAP3K3—cardiovascular system—hypothyroidism	0.00157	0.00236	CbGeAlD
Ruxolitinib—TAOK3—adrenal cortex—hypothyroidism	0.00157	0.00236	CbGeAlD
Ruxolitinib—MKNK2—pituitary gland—hypothyroidism	0.00157	0.00235	CbGeAlD
Ruxolitinib—HIPK2—liver—hypothyroidism	0.00157	0.00235	CbGeAlD
Ruxolitinib—DAPK2—cerebellum—hypothyroidism	0.00156	0.00235	CbGeAlD
Ruxolitinib—CAMK2G—thyroid gland—hypothyroidism	0.00155	0.00233	CbGeAlD
Ruxolitinib—BMP2K—thyroid gland—hypothyroidism	0.00155	0.00233	CbGeAlD
Ruxolitinib—STK16—cerebellum—hypothyroidism	0.00154	0.00231	CbGeAlD
Ruxolitinib—LRRK2—thyroid gland—hypothyroidism	0.00154	0.00231	CbGeAlD
Ruxolitinib—HIPK2—cerebellum—hypothyroidism	0.00153	0.0023	CbGeAlD
Ruxolitinib—RET—pituitary gland—hypothyroidism	0.00153	0.0023	CbGeAlD
Ruxolitinib—ROCK1—testis—hypothyroidism	0.00153	0.0023	CbGeAlD
Ruxolitinib—TAOK3—heart—hypothyroidism	0.00152	0.00228	CbGeAlD
Ruxolitinib—DAPK3—liver—hypothyroidism	0.0015	0.00226	CbGeAlD
Ruxolitinib—CAMK2G—female gonad—hypothyroidism	0.0015	0.00225	CbGeAlD
Ruxolitinib—BMP2K—female gonad—hypothyroidism	0.0015	0.00225	CbGeAlD
Ruxolitinib—CLK2—liver—hypothyroidism	0.00149	0.00224	CbGeAlD
Ruxolitinib—DYRK1A—testis—hypothyroidism	0.00149	0.00224	CbGeAlD
Ruxolitinib—BMPR2—testis—hypothyroidism	0.00148	0.00223	CbGeAlD
Ruxolitinib—LRRK2—female gonad—hypothyroidism	0.00148	0.00223	CbGeAlD
Ruxolitinib—JAK2—gonad—hypothyroidism	0.00148	0.00222	CbGeAlD
Ruxolitinib—DAPK3—cerebellum—hypothyroidism	0.00147	0.00221	CbGeAlD
Ruxolitinib—MAP3K2—adrenal gland—hypothyroidism	0.00146	0.00219	CbGeAlD
Ruxolitinib—MAP3K2—blood—hypothyroidism	0.00146	0.00219	CbGeAlD
Ruxolitinib—CLK2—cerebellum—hypothyroidism	0.00146	0.00219	CbGeAlD
Ruxolitinib—JAK2—pituitary gland—hypothyroidism	0.00145	0.00217	CbGeAlD
Ruxolitinib—MAP3K7—adrenal gland—hypothyroidism	0.00145	0.00217	CbGeAlD
Ruxolitinib—ROCK1—liver—hypothyroidism	0.00144	0.00217	CbGeAlD
Ruxolitinib—MAP3K7—blood—hypothyroidism	0.00144	0.00217	CbGeAlD
Ruxolitinib—TAOK3—cardiovascular system—hypothyroidism	0.00143	0.00215	CbGeAlD
Ruxolitinib—MAP3K3—gonad—hypothyroidism	0.00143	0.00214	CbGeAlD
Ruxolitinib—TYK2—adrenal gland—hypothyroidism	0.00142	0.00213	CbGeAlD
Ruxolitinib—NUAK2—testis—hypothyroidism	0.00142	0.00213	CbGeAlD
Ruxolitinib—TYK2—blood—hypothyroidism	0.00142	0.00213	CbGeAlD
Ruxolitinib—DYRK1A—liver—hypothyroidism	0.00141	0.00212	CbGeAlD
Ruxolitinib—MAP3K2—thyroid gland—hypothyroidism	0.00141	0.00211	CbGeAlD
Ruxolitinib—BMPR2—liver—hypothyroidism	0.0014	0.00211	CbGeAlD
Ruxolitinib—MKNK2—adrenal gland—hypothyroidism	0.0014	0.0021	CbGeAlD
Ruxolitinib—IRAK1—adrenal gland—hypothyroidism	0.0014	0.0021	CbGeAlD
Ruxolitinib—IRAK1—blood—hypothyroidism	0.0014	0.0021	CbGeAlD
Ruxolitinib—MKNK2—blood—hypothyroidism	0.0014	0.0021	CbGeAlD
Ruxolitinib—MAP3K7—thyroid gland—hypothyroidism	0.00139	0.00209	CbGeAlD
Ruxolitinib—MAP3K3—pituitary gland—hypothyroidism	0.00139	0.00209	CbGeAlD
Ruxolitinib—DYRK1A—cerebellum—hypothyroidism	0.00138	0.00207	CbGeAlD
Ruxolitinib—BMPR2—cerebellum—hypothyroidism	0.00137	0.00206	CbGeAlD
Ruxolitinib—TYK2—thyroid gland—hypothyroidism	0.00137	0.00206	CbGeAlD
Ruxolitinib—RET—adrenal gland—hypothyroidism	0.00137	0.00205	CbGeAlD
Ruxolitinib—RET—blood—hypothyroidism	0.00137	0.00205	CbGeAlD
Ruxolitinib—MAP3K2—female gonad—hypothyroidism	0.00136	0.00204	CbGeAlD
Ruxolitinib—IRAK1—thyroid gland—hypothyroidism	0.00135	0.00203	CbGeAlD
Ruxolitinib—MKNK2—thyroid gland—hypothyroidism	0.00135	0.00203	CbGeAlD
Ruxolitinib—MAP3K7—female gonad—hypothyroidism	0.00135	0.00202	CbGeAlD
Ruxolitinib—NUAK2—liver—hypothyroidism	0.00134	0.00201	CbGeAlD
Ruxolitinib—BMP2K—testis—hypothyroidism	0.00133	0.002	CbGeAlD
Ruxolitinib—CAMK2G—testis—hypothyroidism	0.00133	0.002	CbGeAlD
Ruxolitinib—TYK2—female gonad—hypothyroidism	0.00132	0.00199	CbGeAlD
Ruxolitinib—RET—thyroid gland—hypothyroidism	0.00132	0.00198	CbGeAlD
Ruxolitinib—LRRK2—testis—hypothyroidism	0.00132	0.00198	CbGeAlD
Ruxolitinib—NUAK2—cerebellum—hypothyroidism	0.00131	0.00197	CbGeAlD
Ruxolitinib—MKNK2—female gonad—hypothyroidism	0.00131	0.00196	CbGeAlD
Ruxolitinib—IRAK1—female gonad—hypothyroidism	0.00131	0.00196	CbGeAlD
Ruxolitinib—JAK2—adrenal gland—hypothyroidism	0.00129	0.00194	CbGeAlD
Ruxolitinib—JAK2—blood—hypothyroidism	0.00129	0.00194	CbGeAlD
Ruxolitinib—TAOK3—pituitary gland—hypothyroidism	0.00127	0.00191	CbGeAlD
Ruxolitinib—CAMK2G—liver—hypothyroidism	0.00126	0.00189	CbGeAlD
Ruxolitinib—BMP2K—liver—hypothyroidism	0.00126	0.00189	CbGeAlD
Ruxolitinib—JAK2—thyroid gland—hypothyroidism	0.00125	0.00187	CbGeAlD
Ruxolitinib—LRRK2—liver—hypothyroidism	0.00124	0.00187	CbGeAlD
Ruxolitinib—MAP3K3—adrenal gland—hypothyroidism	0.00124	0.00187	CbGeAlD
Ruxolitinib—MAP3K3—blood—hypothyroidism	0.00124	0.00187	CbGeAlD
Ruxolitinib—CAMK2G—cerebellum—hypothyroidism	0.00123	0.00184	CbGeAlD
Ruxolitinib—BMP2K—cerebellum—hypothyroidism	0.00123	0.00184	CbGeAlD
Ruxolitinib—LRRK2—cerebellum—hypothyroidism	0.00122	0.00183	CbGeAlD
Ruxolitinib—MAP3K2—testis—hypothyroidism	0.00121	0.00181	CbGeAlD
Ruxolitinib—JAK2—female gonad—hypothyroidism	0.0012	0.00181	CbGeAlD
Ruxolitinib—MAP3K3—thyroid gland—hypothyroidism	0.0012	0.0018	CbGeAlD
Ruxolitinib—MAP3K7—testis—hypothyroidism	0.0012	0.0018	CbGeAlD
Ruxolitinib—TYK2—testis—hypothyroidism	0.00117	0.00176	CbGeAlD
Ruxolitinib—MAP3K3—female gonad—hypothyroidism	0.00116	0.00174	CbGeAlD
Ruxolitinib—MKNK2—testis—hypothyroidism	0.00116	0.00174	CbGeAlD
Ruxolitinib—IRAK1—testis—hypothyroidism	0.00116	0.00174	CbGeAlD
Ruxolitinib—MAP3K2—liver—hypothyroidism	0.00114	0.00171	CbGeAlD
Ruxolitinib—TAOK3—adrenal gland—hypothyroidism	0.00113	0.0017	CbGeAlD
Ruxolitinib—TAOK3—blood—hypothyroidism	0.00113	0.0017	CbGeAlD
Ruxolitinib—MAP3K7—liver—hypothyroidism	0.00113	0.0017	CbGeAlD
Ruxolitinib—RET—testis—hypothyroidism	0.00113	0.0017	CbGeAlD
Ruxolitinib—MAP3K2—cerebellum—hypothyroidism	0.00111	0.00167	CbGeAlD
Ruxolitinib—TYK2—liver—hypothyroidism	0.00111	0.00167	CbGeAlD
Ruxolitinib—MAP3K7—cerebellum—hypothyroidism	0.0011	0.00166	CbGeAlD
Ruxolitinib—IRAK1—liver—hypothyroidism	0.0011	0.00164	CbGeAlD
Ruxolitinib—MKNK2—liver—hypothyroidism	0.0011	0.00164	CbGeAlD
Ruxolitinib—TAOK3—thyroid gland—hypothyroidism	0.00109	0.00164	CbGeAlD
Ruxolitinib—TYK2—cerebellum—hypothyroidism	0.00108	0.00163	CbGeAlD
Ruxolitinib—MKNK2—cerebellum—hypothyroidism	0.00107	0.00161	CbGeAlD
Ruxolitinib—IRAK1—cerebellum—hypothyroidism	0.00107	0.00161	CbGeAlD
Ruxolitinib—JAK2—testis—hypothyroidism	0.00107	0.0016	CbGeAlD
Ruxolitinib—TAOK3—female gonad—hypothyroidism	0.00106	0.00159	CbGeAlD
Ruxolitinib—RET—cerebellum—hypothyroidism	0.00104	0.00157	CbGeAlD
Ruxolitinib—MAP3K3—testis—hypothyroidism	0.00103	0.00155	CbGeAlD
Ruxolitinib—JAK2—liver—hypothyroidism	0.00101	0.00152	CbGeAlD
Ruxolitinib—JAK2—cerebellum—hypothyroidism	0.000986	0.00148	CbGeAlD
Ruxolitinib—MAP3K3—liver—hypothyroidism	0.000973	0.00146	CbGeAlD
Ruxolitinib—MAP3K3—cerebellum—hypothyroidism	0.00095	0.00143	CbGeAlD
Ruxolitinib—TAOK3—testis—hypothyroidism	0.000938	0.00141	CbGeAlD
Ruxolitinib—TAOK3—liver—hypothyroidism	0.000887	0.00133	CbGeAlD
Ruxolitinib—TAOK3—cerebellum—hypothyroidism	0.000866	0.0013	CbGeAlD
Ruxolitinib—CYP3A4—blood—hypothyroidism	0.000345	0.000518	CbGeAlD
Ruxolitinib—JAK2—DAP12 signaling—VAV3—hypothyroidism	0.000342	0.00102	CbGpPWpGaD
Ruxolitinib—PRKCE—Hemostasis—VAV3—hypothyroidism	0.000342	0.00102	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—CLTC—hypothyroidism	0.00034	0.00102	CbGpPWpGaD
Ruxolitinib—JAK2—IGF1R signaling cascade—IGF1—hypothyroidism	0.000334	0.001	CbGpPWpGaD
Ruxolitinib—JAK3—GPCR downstream signaling—TRH—hypothyroidism	0.000334	0.001	CbGpPWpGaD
Ruxolitinib—ROCK1—Focal Adhesion—IGF1—hypothyroidism	0.000329	0.000985	CbGpPWpGaD
Ruxolitinib—IRAK1—Cytokine Signaling in Immune system—PRL—hypothyroidism	0.000327	0.00098	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—TRH—hypothyroidism	0.000327	0.000979	CbGpPWpGaD
Ruxolitinib—MAP3K7—Adaptive Immune System—CLTC—hypothyroidism	0.000326	0.000975	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—TSHB—hypothyroidism	0.000323	0.000965	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—TSHR—hypothyroidism	0.000323	0.000965	CbGpPWpGaD
Ruxolitinib—JAK2—Fc epsilon receptor (FCERI) signaling—VAV3—hypothyroidism	0.000322	0.000962	CbGpPWpGaD
Ruxolitinib—JAK2—DAP12 interactions—VAV3—hypothyroidism	0.000322	0.000962	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—CLTC—hypothyroidism	0.000321	0.00096	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by GPCR—TSHR—hypothyroidism	0.000321	0.000959	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by GPCR—TSHB—hypothyroidism	0.000321	0.000959	CbGpPWpGaD
Ruxolitinib—TYK2—Cytokine Signaling in Immune system—PRL—hypothyroidism	0.000318	0.000951	CbGpPWpGaD
Ruxolitinib—PHKG2—Metabolism—PIK3C2A—hypothyroidism	0.000311	0.00093	CbGpPWpGaD
Ruxolitinib—MAP3K7—Cytokine Signaling in Immune system—PRL—hypothyroidism	0.000308	0.000923	CbGpPWpGaD
Ruxolitinib—PRKCE—Innate Immune System—VAV3—hypothyroidism	0.000308	0.000921	CbGpPWpGaD
Ruxolitinib—PRKG2—Metabolism—SLC5A5—hypothyroidism	0.000307	0.000919	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—SH2B3—hypothyroidism	0.000306	0.000915	CbGpPWpGaD
Ruxolitinib—GRK1—Disease—PRL—hypothyroidism	0.000305	0.000911	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—TRH—hypothyroidism	0.000304	0.000908	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—CLTC—hypothyroidism	0.0003	0.000899	CbGpPWpGaD
Ruxolitinib—JAK3—GPCR downstream signaling—TSHB—hypothyroidism	0.000298	0.000892	CbGpPWpGaD
Ruxolitinib—JAK3—GPCR downstream signaling—TSHR—hypothyroidism	0.000298	0.000892	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling by NGF—VAV3—hypothyroidism	0.000298	0.000891	CbGpPWpGaD
Ruxolitinib—JAK1—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	0.000296	0.000887	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—TSHB—hypothyroidism	0.000292	0.000873	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—TSHR—hypothyroidism	0.000292	0.000873	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by NGF—VAV3—hypothyroidism	0.000289	0.000865	CbGpPWpGaD
Ruxolitinib—JAK3—Hemostasis—VAV3—hypothyroidism	0.000288	0.000863	CbGpPWpGaD
Ruxolitinib—JAK1—GPCR downstream signaling—TRH—hypothyroidism	0.000288	0.000861	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—SH2B3—hypothyroidism	0.000288	0.00086	CbGpPWpGaD
Ruxolitinib—ROCK1—GPCR downstream signaling—TRH—hypothyroidism	0.000283	0.000846	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—CLTC—hypothyroidism	0.000276	0.000826	CbGpPWpGaD
Ruxolitinib—PHKG2—Disease—PRL—hypothyroidism	0.000275	0.000824	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—TSHB—hypothyroidism	0.000271	0.00081	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—TSHR—hypothyroidism	0.000271	0.00081	CbGpPWpGaD
Ruxolitinib—CYP3A4—liver—hypothyroidism	0.000269	0.000405	CbGeAlD
Ruxolitinib—JAK2—Platelet activation, signaling and aggregation—VAV3—hypothyroidism	0.000269	0.000806	CbGpPWpGaD
Ruxolitinib—JAK2—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—hypothyroidism	0.000265	0.000794	CbGpPWpGaD
Ruxolitinib—TYK2—Axon guidance—VAV3—hypothyroidism	0.000262	0.000783	CbGpPWpGaD
Ruxolitinib—PHKG2—Metabolism—SLC5A5—hypothyroidism	0.000261	0.000781	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—TRH—hypothyroidism	0.000261	0.000781	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—SH2B3—hypothyroidism	0.00026	0.000778	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—TRH—hypothyroidism	0.000257	0.000769	CbGpPWpGaD
Ruxolitinib—JAK1—GPCR downstream signaling—TSHR—hypothyroidism	0.000256	0.000767	CbGpPWpGaD
Ruxolitinib—JAK1—GPCR downstream signaling—TSHB—hypothyroidism	0.000256	0.000767	CbGpPWpGaD
Ruxolitinib—JAK1—Developmental Biology—VAV3—hypothyroidism	0.000253	0.000757	CbGpPWpGaD
Ruxolitinib—ROCK1—GPCR downstream signaling—TSHR—hypothyroidism	0.000252	0.000754	CbGpPWpGaD
Ruxolitinib—ROCK1—GPCR downstream signaling—TSHB—hypothyroidism	0.000252	0.000754	CbGpPWpGaD
Ruxolitinib—ROCK1—Developmental Biology—VAV3—hypothyroidism	0.000249	0.000744	CbGpPWpGaD
Ruxolitinib—JAK1—Hemostasis—VAV3—hypothyroidism	0.000248	0.000742	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—CLTC—hypothyroidism	0.000246	0.000736	CbGpPWpGaD
Ruxolitinib—JAK2—Cytokine Signaling in Immune system—PRL—hypothyroidism	0.000241	0.000721	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—TSHB—hypothyroidism	0.000233	0.000697	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—TSHR—hypothyroidism	0.000233	0.000697	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—TSHR—hypothyroidism	0.000229	0.000685	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—TSHB—hypothyroidism	0.000229	0.000685	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—PRL—hypothyroidism	0.000227	0.000679	CbGpPWpGaD
Ruxolitinib—JAK1—Innate Immune System—VAV3—hypothyroidism	0.000223	0.000668	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by NGF—VAV3—hypothyroidism	0.000219	0.000656	CbGpPWpGaD
Ruxolitinib—PRKCE—GPCR downstream signaling—VAV3—hypothyroidism	0.000216	0.000646	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—PRL—hypothyroidism	0.000213	0.000638	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—TRH—hypothyroidism	0.000213	0.000636	CbGpPWpGaD
Ruxolitinib—PRKCE—Hemostasis—IGF1—hypothyroidism	0.00021	0.00063	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—CLTC—hypothyroidism	0.00021	0.000628	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—VAV3—hypothyroidism	0.00021	0.000628	CbGpPWpGaD
Ruxolitinib—PRKCE—GPCR downstream signaling—AVP—hypothyroidism	0.000208	0.000623	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—CLTC—hypothyroidism	0.000208	0.000621	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—CLTC—hypothyroidism	0.000204	0.00061	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—SH2B3—hypothyroidism	0.000202	0.000605	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—AVP—hypothyroidism	0.000202	0.000605	CbGpPWpGaD
Ruxolitinib—JAK2—Axon guidance—VAV3—hypothyroidism	0.000198	0.000593	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—CLTC—hypothyroidism	0.000198	0.000592	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—VAV3—hypothyroidism	0.000197	0.00059	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by GPCR—VAV3—hypothyroidism	0.000196	0.000587	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—PRL—hypothyroidism	0.000194	0.00058	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—PRL—hypothyroidism	0.000193	0.000577	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—TRH—hypothyroidism	0.000193	0.000577	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—AVP—hypothyroidism	0.00019	0.000569	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—TSHB—hypothyroidism	0.000189	0.000567	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—TSHR—hypothyroidism	0.000189	0.000567	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by GPCR—AVP—hypothyroidism	0.000189	0.000565	CbGpPWpGaD
Ruxolitinib—TYK2—Developmental Biology—VAV3—hypothyroidism	0.000187	0.000559	CbGpPWpGaD
Ruxolitinib—JAK3—GPCR downstream signaling—VAV3—hypothyroidism	0.000182	0.000545	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—TRH—hypothyroidism	0.000179	0.000537	CbGpPWpGaD
Ruxolitinib—PRKCE—Immune System—VAV3—hypothyroidism	0.000179	0.000536	CbGpPWpGaD
Ruxolitinib—PRKCE—Disease—PRL—hypothyroidism	0.000179	0.000535	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—CLTC—hypothyroidism	0.000179	0.000534	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—VAV3—hypothyroidism	0.000178	0.000534	CbGpPWpGaD
Ruxolitinib—JAK3—Hemostasis—IGF1—hypothyroidism	0.000178	0.000531	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—PRL—hypothyroidism	0.000177	0.000531	CbGpPWpGaD
Ruxolitinib—JAK3—GPCR downstream signaling—AVP—hypothyroidism	0.000176	0.000525	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—CLTC—hypothyroidism	0.000176	0.000525	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—PRL—hypothyroidism	0.000173	0.000519	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—AVP—hypothyroidism	0.000172	0.000514	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—TSHR—hypothyroidism	0.000172	0.000514	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—TSHB—hypothyroidism	0.000172	0.000514	CbGpPWpGaD
Ruxolitinib—IRAK1—Innate Immune System—VAV3—hypothyroidism	0.00017	0.000508	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—SH2B3—hypothyroidism	0.000169	0.000505	CbGpPWpGaD
Ruxolitinib—JAK2—Platelet activation, signaling and aggregation—IGF1—hypothyroidism	0.000166	0.000496	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—VAV3—hypothyroidism	0.000166	0.000495	CbGpPWpGaD
Ruxolitinib—TYK2—Innate Immune System—VAV3—hypothyroidism	0.000165	0.000493	CbGpPWpGaD
Ruxolitinib—CAMK2G—Immune System—VAV3—hypothyroidism	0.000164	0.000491	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—PRL—hypothyroidism	0.000163	0.000489	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—TRH—hypothyroidism	0.000161	0.000481	CbGpPWpGaD
Ruxolitinib—PRKG2—Metabolism—POMC—hypothyroidism	0.000161	0.000481	CbGpPWpGaD
Ruxolitinib—MAP3K3—Immune System—VAV3—hypothyroidism	0.00016	0.00048	CbGpPWpGaD
Ruxolitinib—MAP3K7—Innate Immune System—VAV3—hypothyroidism	0.00016	0.000479	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—TSHB—hypothyroidism	0.00016	0.000478	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—TSHR—hypothyroidism	0.00016	0.000478	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—AVP—hypothyroidism	0.000159	0.000477	CbGpPWpGaD
Ruxolitinib—JAK1—GPCR downstream signaling—VAV3—hypothyroidism	0.000157	0.000469	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—CLTC—hypothyroidism	0.000154	0.000462	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—TRH—hypothyroidism	0.000154	0.000462	CbGpPWpGaD
Ruxolitinib—ROCK1—GPCR downstream signaling—VAV3—hypothyroidism	0.000154	0.000461	CbGpPWpGaD
Ruxolitinib—JAK1—Hemostasis—IGF1—hypothyroidism	0.000153	0.000457	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—TRH—hypothyroidism	0.000152	0.000454	CbGpPWpGaD
Ruxolitinib—JAK3—Immune System—VAV3—hypothyroidism	0.000151	0.000453	CbGpPWpGaD
Ruxolitinib—JAK1—GPCR downstream signaling—AVP—hypothyroidism	0.000151	0.000452	CbGpPWpGaD
Ruxolitinib—ROCK1—GPCR downstream signaling—AVP—hypothyroidism	0.000149	0.000445	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—TRH—hypothyroidism	0.000146	0.000437	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—TSHB—hypothyroidism	0.000143	0.000429	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—TSHR—hypothyroidism	0.000143	0.000429	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—SH2B3—hypothyroidism	0.000142	0.000426	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—VAV3—hypothyroidism	0.000142	0.000426	CbGpPWpGaD
Ruxolitinib—JAK2—Developmental Biology—VAV3—hypothyroidism	0.000142	0.000423	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—PRL—hypothyroidism	0.000141	0.000421	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—VAV3—hypothyroidism	0.00014	0.000419	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—VAV3—hypothyroidism	0.000139	0.000415	CbGpPWpGaD
Ruxolitinib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000138	0.000414	CbGpPWpGaD
Ruxolitinib—PRKCE—GPCR downstream signaling—POMC—hypothyroidism	0.000138	0.000414	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—TSHB—hypothyroidism	0.000138	0.000411	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—TSHR—hypothyroidism	0.000138	0.000411	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—AVP—hypothyroidism	0.000137	0.000411	CbGpPWpGaD
Ruxolitinib—PHKG2—Metabolism—POMC—hypothyroidism	0.000137	0.000409	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—CLTC—hypothyroidism	0.000136	0.000406	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—TSHB—hypothyroidism	0.000135	0.000405	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—TSHR—hypothyroidism	0.000135	0.000405	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—AVP—hypothyroidism	0.000135	0.000404	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—POMC—hypothyroidism	0.000134	0.000402	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—CLTC—hypothyroidism	0.000132	0.000394	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—TSHB—hypothyroidism	0.00013	0.00039	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—TSHR—hypothyroidism	0.00013	0.00039	CbGpPWpGaD
Ruxolitinib—JAK1—Immune System—VAV3—hypothyroidism	0.00013	0.000389	CbGpPWpGaD
Ruxolitinib—JAK1—Disease—PRL—hypothyroidism	0.00013	0.000389	CbGpPWpGaD
Ruxolitinib—PRKG2—Signaling Pathways—IGF1—hypothyroidism	0.000129	0.000387	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—CLTC—hypothyroidism	0.000128	0.000382	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—POMC—hypothyroidism	0.000126	0.000378	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling by GPCR—POMC—hypothyroidism	0.000126	0.000376	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—PRL—hypothyroidism	0.000125	0.000375	CbGpPWpGaD
Ruxolitinib—JAK2—Innate Immune System—VAV3—hypothyroidism	0.000125	0.000374	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—SH2B3—hypothyroidism	0.000123	0.000367	CbGpPWpGaD
Ruxolitinib—GRK1—Signaling Pathways—IGF1—hypothyroidism	0.000122	0.000364	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—SH2B3—hypothyroidism	0.000121	0.000361	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—TRH—hypothyroidism	0.000117	0.000351	CbGpPWpGaD
Ruxolitinib—JAK3—GPCR downstream signaling—POMC—hypothyroidism	0.000117	0.000349	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—VAV3—hypothyroidism	0.000116	0.000347	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—POMC—hypothyroidism	0.000114	0.000342	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—TRH—hypothyroidism	0.000114	0.000341	CbGpPWpGaD
Ruxolitinib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000112	0.000335	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—AVP—hypothyroidism	0.000112	0.000334	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—TRH—hypothyroidism	0.00011	0.000331	CbGpPWpGaD
Ruxolitinib—BMPR2—Signaling Pathways—IGF1—hypothyroidism	0.00011	0.000329	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—PRL—hypothyroidism	0.000107	0.00032	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling by GPCR—POMC—hypothyroidism	0.000106	0.000317	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—PRL—hypothyroidism	0.000106	0.000316	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—VAV3—hypothyroidism	0.000105	0.000315	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—TSHB—hypothyroidism	0.000105	0.000313	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—TSHR—hypothyroidism	0.000105	0.000313	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—PRL—hypothyroidism	0.000104	0.000311	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—TSHB—hypothyroidism	0.000102	0.000304	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—TSHR—hypothyroidism	0.000102	0.000304	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—AVP—hypothyroidism	0.000101	0.000303	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—PRL—hypothyroidism	0.000101	0.000301	CbGpPWpGaD
Ruxolitinib—JAK1—GPCR downstream signaling—POMC—hypothyroidism	0.0001	0.0003	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—CLTC—hypothyroidism	9.99e-05	0.000299	CbGpPWpGaD
Ruxolitinib—IRAK1—Immune System—VAV3—hypothyroidism	9.89e-05	0.000296	CbGpPWpGaD
Ruxolitinib—ROCK1—GPCR downstream signaling—POMC—hypothyroidism	9.87e-05	0.000295	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—TSHB—hypothyroidism	9.85e-05	0.000295	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—TSHR—hypothyroidism	9.85e-05	0.000295	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—VAV3—hypothyroidism	9.78e-05	0.000293	CbGpPWpGaD
Ruxolitinib—TYK2—Immune System—VAV3—hypothyroidism	9.61e-05	0.000287	CbGpPWpGaD
Ruxolitinib—TYK2—Disease—PRL—hypothyroidism	9.59e-05	0.000287	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—AVP—hypothyroidism	9.42e-05	0.000282	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—SH2B3—hypothyroidism	9.32e-05	0.000279	CbGpPWpGaD
Ruxolitinib—MAP3K7—Immune System—VAV3—hypothyroidism	9.32e-05	0.000279	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling by GPCR—POMC—hypothyroidism	9.12e-05	0.000273	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—PRL—hypothyroidism	9.09e-05	0.000272	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—SH2B3—hypothyroidism	9.05e-05	0.000271	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling by GPCR—POMC—hypothyroidism	8.97e-05	0.000268	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—PRL—hypothyroidism	8.94e-05	0.000268	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—SH2B3—hypothyroidism	8.78e-05	0.000263	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—VAV3—hypothyroidism	8.77e-05	0.000263	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—TRH—hypothyroidism	8.63e-05	0.000258	CbGpPWpGaD
Ruxolitinib—JAK2—Hemostasis—IGF1—hypothyroidism	8.55e-05	0.000256	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—AVP—hypothyroidism	8.45e-05	0.000253	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—VAV3—hypothyroidism	8.41e-05	0.000252	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—VAV3—hypothyroidism	8.27e-05	0.000248	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—AVP—hypothyroidism	8.1e-05	0.000242	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—AVP—hypothyroidism	7.97e-05	0.000239	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—VAV3—hypothyroidism	7.97e-05	0.000238	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—PRL—hypothyroidism	7.87e-05	0.000235	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—TSHB—hypothyroidism	7.69e-05	0.00023	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—TSHR—hypothyroidism	7.69e-05	0.00023	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—AVP—hypothyroidism	7.68e-05	0.00023	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—POMC—hypothyroidism	7.42e-05	0.000222	CbGpPWpGaD
Ruxolitinib—JAK2—Immune System—VAV3—hypothyroidism	7.28e-05	0.000218	CbGpPWpGaD
Ruxolitinib—JAK2—Disease—PRL—hypothyroidism	7.27e-05	0.000217	CbGpPWpGaD
Ruxolitinib—PRKCE—Signaling Pathways—IGF1—hypothyroidism	7.14e-05	0.000214	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—IYD—hypothyroidism	7.03e-05	0.00021	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—PRL—hypothyroidism	6.92e-05	0.000207	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—SH2B3—hypothyroidism	6.86e-05	0.000205	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling by GPCR—POMC—hypothyroidism	6.73e-05	0.000201	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—PRL—hypothyroidism	6.71e-05	0.000201	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—PRL—hypothyroidism	6.51e-05	0.000195	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—VAV3—hypothyroidism	6.4e-05	0.000191	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—POMC—hypothyroidism	6.26e-05	0.000187	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—VAV3—hypothyroidism	6.21e-05	0.000186	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—AVP—hypothyroidism	6.16e-05	0.000184	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—VAV3—hypothyroidism	6.02e-05	0.00018	CbGpPWpGaD
Ruxolitinib—JAK3—Signaling Pathways—IGF1—hypothyroidism	6.02e-05	0.00018	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—AVP—hypothyroidism	5.98e-05	0.000179	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—ATP5O—hypothyroidism	5.97e-05	0.000179	CbGpPWpGaD
Ruxolitinib—CYP3A4—Biological oxidations—POMC—hypothyroidism	5.96e-05	0.000178	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—AVP—hypothyroidism	5.8e-05	0.000174	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—TPO—hypothyroidism	5.62e-05	0.000168	CbGpPWpGaD
Ruxolitinib—JAK2—GPCR downstream signaling—POMC—hypothyroidism	5.62e-05	0.000168	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—POMC—hypothyroidism	5.39e-05	0.000161	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—POMC—hypothyroidism	5.3e-05	0.000158	CbGpPWpGaD
Ruxolitinib—JAK1—Signaling Pathways—IGF1—hypothyroidism	5.18e-05	0.000155	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling by GPCR—POMC—hypothyroidism	5.1e-05	0.000153	CbGpPWpGaD
Ruxolitinib—ROCK1—Signaling Pathways—IGF1—hypothyroidism	5.1e-05	0.000152	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—PRL—hypothyroidism	5.09e-05	0.000152	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—VAV3—hypothyroidism	4.71e-05	0.000141	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—AVP—hypothyroidism	4.53e-05	0.000136	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—POMC—hypothyroidism	4.1e-05	0.000123	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—POMC—hypothyroidism	3.98e-05	0.000119	CbGpPWpGaD
Ruxolitinib—IRAK1—Signaling Pathways—IGF1—hypothyroidism	3.94e-05	0.000118	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—POMC—hypothyroidism	3.86e-05	0.000115	CbGpPWpGaD
Ruxolitinib—TYK2—Signaling Pathways—IGF1—hypothyroidism	3.82e-05	0.000114	CbGpPWpGaD
Ruxolitinib—MAP3K7—Signaling Pathways—IGF1—hypothyroidism	3.71e-05	0.000111	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—POMC—hypothyroidism	3.01e-05	9.02e-05	CbGpPWpGaD
Ruxolitinib—JAK2—Signaling Pathways—IGF1—hypothyroidism	2.9e-05	8.67e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—TSHB—hypothyroidism	2.6e-05	7.78e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—PIK3C2A—hypothyroidism	2.32e-05	6.94e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—SLC5A5—hypothyroidism	1.95e-05	5.82e-05	CbGpPWpGaD
Ruxolitinib—CYP3A4—Metabolism—POMC—hypothyroidism	1.02e-05	3.05e-05	CbGpPWpGaD
